We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Jennifer L. Wilkie

Gowling WLG

Results 1 to 5 of 27
Most popular |Most recent


The USMCA: What does it mean for patents and the pharmaceutical industry?

USA, Canada - October 5 2018 In a joint statement on September 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on...

Justin Smith, Jenny Thistle, John Norman PhD.


The skinny on skinny labels

Canada - December 20 2017 In a recent decision of Federal Court (Bristol-Myers Squibb Canada v Apotex Inc., 2017 FC 1061), Justice Lafrenière dismissed the prohibition...

Alexander Camenzind.


Government of Canada finalizes amended NOC Regulations and new CSP Regulations

Canada - September 11 2017 The Government of Canada has finalized the Certificate of Supplementary Protection Regulations (the "CSP Regulations") and the amended Patented...


What the Supreme Court of Canada was not told about patent utility

Canada - May 11 2017 On November 8, 2016 the Supreme Court of Canada (“SCC”) heard an appeal by Astrazeneca regarding the validity of a patent covering its NEXIUM product...

Jay Zakaïb.


Federal Court deviates from established tests for patent listing Gilead Sciences, Inc. v. Canada (Health)

Canada - March 22 2016 In the decision summarized below, Apotex successfully obtained a dismissal of Gilead's application for a prohibition order in respect of Canadian...

Patrick Cashin, Jay Zakaïb.